BioversityMA’s Post

Pacific Economic Development Canada | Développement économique Canada pour le Pacifique has awarded $5 million to SBME for a new Biodevice Foundry set to launch in our new building in January 2025. A $2.5 million donation from the Conconi Family Foundation helped to unlock the federal grant.    The Biodevice Foundry is a state-of-the-art facility for designing, prototyping, fabricating and testing biodevices that will help accelerate biomedical innovation and grow the life sciences industry to transform health locally and globally.     “The SBME community is thrilled to receive this funding—it will help discover and translate new biodevices that will impact patient health and fuel life sciences industry both locally and globally. We are excited about the new collaborations between industry and academia this facility will support.” Dr. Peter Zandstra.    Explore how the Biodevice Foundry will help impact patient health and bolster Canada’s life sciences and biotech sector.    https://lnkd.in/e76GJ3Jr 

What makes philanthropy essential to us? In my opinion, the need to eradicate societal problems and bring forth beneficial changes in people's lives. What do we envision at Mankind Pharma? Supporting the 'act of giving' through CSR associations, sustainable activities, and—above all—active community engagement.    In my recent conversation with TheCSRUniverse, I got an opportunity to enlighten MANKIND PHARMA LTD’s philanthropic objectives and endeavours. As we remain dedicated to leaving a long-lasting legacy of compassion, we constantly navigate the evolving field of CSR. #interview #csr #society #philanthropy

It is always fun to bring an idea to full fruition.

Why are we so confident our Future Founders course is worth it? Here's just one example... Read how Northumbria University's Sterghios A. Moschos FRSC FIBMS MRSB spinout PulmoBioMed Ltd. has raised £1.4m investment to change lives with a non-invasive test that could detect asthma and other diseases earlier. Many of our Future Founders have gone on to launch their own spinout businesses with support from Northern Accelerator and IP & Commercialisation specialists at their university. If you're an academic at Durham University, Newcastle University, Northumbria University or University of York and you're thinking about commercialisation as a route to make an impact with your research, apply for the next cohort by 7 March. https://lnkd.in/ekwwe2sa

Be sure to read this case study for Crohn's and Colitis Awareness Week!

Genomes By Design new gene editing method could allow an “unprecedented level of control for manipulating genomes.” The existing CRISPR-Cas9 technique allows snippets of genetic code to be cut and replaced with precision. But it only allows small cuts and changes, and works by damaging the target. The new “bridge editing” system, which like CRISPR uses molecular machinery found in bacteria, allows huge sections of a genome to be altered: One researcher told New Scientist that it would allow scientists to “move beyond inserting individual genes to do chromosome-scale genome engineering.” It has not yet been shown to work in human cells, but even if it does not, will likely be modified so that it can.

What inspires big gifts? Big Ideas. We believe in the power of big ideas and donor partnerships to inspire real change. Check out our latest article to learn more about developing those big ideas and cultivating those partnerships: bit.ly/3vYDfpe

🚀 As we announce a new wave of funding, across research projects in the healthspan space, our CEO Dr Mehmood Khan reflects on Hevolution’s purpose of catalysing the shift from lifespan to healthspan and the mountain we’re committed to climbing as the world's largest philanthropic funder of geroscience: 💡  “We’re spending a decade of life in poor health— this is a decade too many. Our current healthcare system focuses more on intervention, but our goal is to address the underlying causes of aging and age-related diseases. Geroscience and healthspan science are critically underfunded, which is why Hevolution is stepping up to bridge this gap.” ➡️ Learn more about the institutes we’re funding here  https://lnkd.in/gNvjtwnY

Considering the possibility of starting a lab? Don't miss this seminar to learn more about funding a new lab from the WashU Department of Medicine.

 “The idea is simple: we’re stronger when we work together.” As a nonprofit organization, Fogarty Innovation serves as an independent catalyst for conversations among diverse stakeholders. “We are a safe haven where innovators, academia, industry, and government can discuss challenges openly and agree to work together to find solutions,” says Fogarty chief alliance officer Allie Gregorian. Learn more about Fogarty's alliance program and how you can get involved - from attending our free educational events to developing a bespoke partnership that helps strengthen the medtech ecosystem and improve human health: https://lnkd.in/gGmGYtqV